Phys · cardiovascular
Adult Congenital Heart Disease
Also known as Adult Congenital Heart Disease · adult congenital heart disease · ACHD · grown-up congenital heart disease · GUCH
Consultant-physician depth guide to Adult Congenital Heart Disease for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.
On this page
Study tools
Your progress
Saved on this device.
Practise this topic
Target exams
Red flags
- Missed urgency or delayed escalation in Adult Congenital Heart Disease turns a salvageable presentation into preventable harm
- Treating the label without confirming the mechanism leads to wrong therapy in Adult Congenital Heart Disease
- Ignoring multimorbidity and drug interactions while managing Adult Congenital Heart Disease is a classic exam and clinical trap
- Failing to document the shared plan and safety-net advice after Adult Congenital Heart Disease loses follow-through
- Using recalled thresholds without a cited source is forbidden — verify before acting
Meet the patient
A 34-year-old woman with repaired tetralogy of Fallot is well in clinic on Monday, then arrives at 3am on Sunday with rapid palpitation and a syncopal drop. The monitor shows a wide-complex tachycardia at 190. She is the archetypal ACHD patient — surgically cured on paper, yet carrying the scarred substrate that makes late arrhythmia and sudden death her dominant risk.[1][10]
Hold two questions for every ACHD patient you meet: is the current rhythm or physiology tolerated, and what is the underlying lesion? The lesion names the late failure phenotype, and the phenotype names the treatment lever.[1]
References10ShowHide
- [1]Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines J Am Coll Cardiol, 2019.PMID 30121239
- [2]Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy Eur Heart J, 2018.PMID 30165544
- [3]Galiè N, Beghetti M, Gatzoulis MA, et al. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study Circulation, 2006.PMID 16801459
- [4]Apitz C, Webb GD, Redington AN Tetralogy of Fallot Lancet, 2009.PMID 19683809
- [5]Choudhary P, Canniffe C, Jackson DJ, et al. Late outcomes in adults with coarctation of the aorta Heart, 2015.PMID 25810155
- [6]Liu A, Diller GP, Moons P, et al. Changing epidemiology of congenital heart disease: effect on outcomes and quality of care in adults Nat Rev Cardiol, 2023.PMID 36045220
- [7]Diller GP, Kempny A, Alonso-Gonzalez R, Swan L, et al. New York Heart Association (NYHA) classification in adults with congenital heart disease: relation to objective measures of exercise and outcome Eur Heart J Qual Care Clin Outcomes, 2018.PMID 28950356
- [8]Geva T, Wald RM, Bucholz E, et al. Long-Term Management of Right Ventricular Outflow Tract Dysfunction in Repaired Tetralogy of Fallot: A Scientific Statement From the American Heart Association Circulation, 2024.PMID 39569497
- [9]Waldmann V, Laredo M, Abadir S, et al. Atrial fibrillation in adults with congenital heart disease Int J Cardiol, 2019.PMID 30712848
- [10]Diller GP, Arvanitaki A, Opotowsky AR, et al. Lifespan Perspective on Congenital Heart Disease Research: JACC State-of-the-Art Review J Am Coll Cardiol, 2021.PMID 33926659